热门资讯> 正文
Aadi Bioscience GAAP每股收益-0.68美元，损失0.06美元，540万美元的收入损失129万美元
2024-05-08 20:04
- Aadi Bioscience press release (NASDAQ:AADI): Q1 GAAP EPS of -$0.68 misses by $0.06.
- Revenue of $5.4M (-8.5% Y/Y) misses by $1.29M.
- Cash, cash equivalents and short-term investments as of March 31, 2024, were $88.3 million as compared to $108.8 million as of December 31, 2023, which is expected to fund operations into Q4 2025 based on current plans.
More on Aadi Bioscience
- Seeking Alpha’s Quant Rating on Aadi Bioscience
- Historical earnings data for Aadi Bioscience
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
